Intellectual Property Magazine
Biotech start-up secures Covid licensing agreement
InVixa wins lucrative licensing agreement with university
Ben Wodecki
A biopharmaceutical start-up which is developing inhalable statins to treat Covid-19, has secured an exclusive licensing deal
with the University of California (UC), Davis.